Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Barts Health NHS Trust
2nd Floor, 9 Prescot Street
Aldgate
E1 8PR
UK
Contact person: Mr Fabien Affonso
Telephone: +44 20737770004103
E-mail: Fabien.Affonso@nhs.net
NUTS: UK
Internet address(es)
Main address: http://www.bartshealth.nhs.uk
Address of the buyer profile: http://www.bartshealth.nhs.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Manufacture and Delivery of Dose Specific and Dose Banded Systemic Anti-Cancer Treatments
Reference number: DN406495
II.1.2) Main CPV code
85149000
II.1.3) Type of contract
Services
II.1.4) Short description
The Trust is the cancer centre for North East London and provides a medical and haematological oncologyservice including bone marrow transplantation. The chemotherapy pharmacy department has a licensed chemotherapy production unit, providing over 45 000 doses of Systemic Anti-Cancer Treatments (SACT) per year.
Demand for the provision of SACT has been rising consistently year on year. As such the department has developed a strategy to meet this demand and ensure that patient treatment requirements can be met. This strategy includes maximising efficiency of our existing production capacity by outsourcing doses that can be manufactured externally, to quality standards and that will be safe for the patient.
The outsourced doses will be purchased in the form of both ready made dose banded products and patient specific doses.
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The following drugs may be required (not exhaustive and subject to change as new drugs are commissioned).
Patient specific doses of systemic anti-cancer treatments:
Bleomycin infusion
Bleomycin injection
Bortezomib injection
Carboplatin infusion
Cetuximab infusion
Cisplatin infusion
Cyclophosphamide infusion
Cytarabine injection
Cytarabine infusion
Daratumumab infusion
Docetaxel infusion
Etoposide infusion
Fluorouracil infusion in bags and LV2, LV5 and LV10 pumps
Gemcitabine infusion
Ifosfamide infusion
Irinotecan infusion
Methotrexate infusion
Methotrexate injection
Oxaliplatin infusion
Paclitaxel infusion
Pembrolizumab infusion
Pemetrexed infusion
Trastuzumab infusion (both branded and biosimilar)
Vincristine infusion
Vincristine injection
Vinorelbine infusion
Dose Banded:
Bleomycin infusion
Bortezomib injection
Carboplatin infusion
Cisplatin infusion
Cyclophosphamide infusion
Docetaxel infusion
Doxorubicin
Fluorouracil infusion in 100ml bags
Fluorouracil infusion in LV5 pumps
Gemcitabine infusion
Irinotecan infusion
Oxaliplatin infusion
Paclitaxel infusion
Pembrolizumab infusion
Pemetrexed infusion
Trastuzumab infusion (both branded and biosimilar)
Vincristine infusion
Vinblastine infusion
II.2.5) Award criteria
Quality criterion: SQ and service and quality questions
/ Weighting: 70
Price
/ Weighting:
30
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.9) Information about termination of call for competition in the form of a prior information notice
The contracting authority will not award any further contracts based on the above prior information notice
Section V: Award of contract
Contract No: Abandoned
A contract/lot is awarded:
No
V.1 Information on non-award
The contract/lot is not awarded
Other reasons (discontinuation of procedure)
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Barts Health NHS Trust
London
UK
VI.5) Date of dispatch of this notice
11/06/2019